End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.79 USD | +2.35% | +3.23% | +2.57% |
May. 10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
May. 09 | Zura Bio Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 322M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -59M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.97
x | P/E ratio 2025 * |
-6.29
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.2% |
1 day | +2.35% | ||
1 week | +3.23% | ||
Current month | +12.18% | ||
1 month | +42.56% | ||
3 months | +20.96% | ||
6 months | +8.86% | ||
Current year | +2.57% |
Managers | Title | Age | Since |
---|---|---|---|
Someit Sidhu
FOU | Founder | 34 | 22-01-17 |
Robert Lisicki
CEO | Chief Executive Officer | 57 | Jan. 07 |
Verender Badial
DFI | Director of Finance/CFO | 51 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amit Munshi
CHM | Chairman | 56 | 23-02-28 |
Steven Schoch
BRD | Director/Board Member | 64 | 23-02-28 |
Sandeep Kulkarni
BRD | Director/Board Member | 43 | 22-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 5.16 | +7.72% | 256,541 |
24-05-13 | 4.79 | +2.35% | 162,379 |
24-05-10 | 4.68 | +1.74% | 164,766 |
24-05-09 | 4.6 | -2.34% | 101,720 |
24-05-08 | 4.71 | +1.51% | 93,882 |
End-of-day quote Nasdaq, May 12, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.57% | 322M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.29% | 21.25B | |
-5.71% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- ZURA Stock